Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
J Gen Intern Med. 2005 Jul;20(7):662-5.

The new medicare drug benefit: formularies and their potential effects on access to medications.

Author information

  • 1Department of Health Care Policy, Harvard Medical School, Boston, Mass., USA. huskamp@hcp.med.harvard.edu

Abstract

During congressional debate over the Medicare Part D prescription drug benefit, much attention was focused on nominal benefit design. Relatively little attention was paid to details about how plans would operate, such as the design of drug formularies. Yet, formularies will be important tools for controlling costs, and may be as important as nominal benefit design in determining enrollees' access to medications and out-of-pocket costs. We describe Part D plan incentives and how they may influence formulary design, and then provide recommendations for Part D formulary implementation. We encourage the Centers for Medicare & Medicaid Services (CMS) to develop standardized tools to provide physicians and patients with up-to-date and easily accessible information about covered drugs on each plan's formulary (perhaps via a central website) and a national set of easy-to-follow procedures for reconsideration and appeals. Such efforts should reduce administrative burden and better allow physicians to help patients obtain needed medications.

PMID:
16050866
[PubMed - indexed for MEDLINE]
PMCID:
PMC1403290
Free PMC Article

Images from this publication.See all images (1)Free text

Figure 1
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for PubMed Central
    Loading ...
    Write to the Help Desk